Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M12,480Revenue $M3,050Net Margin (%)8.9Z-Score0
Enterprise Value $M12,818EPS $8.4Operating Margin %22.6F-Score0
P/E(ttm))46.5Cash Flow Per Share $8.0Pre-tax Margin (%)13.4Higher ROA y-yN
Price/Book6.310-y EBITDA Growth Rate %10.0Quick Ratio0Cash flow > EarningsN
Price/Sales3.95-y EBITDA Growth Rate %1.6Current Ratio0Lower Leverage y-yN
Price/Cash Flow12.2y-y EBITDA Growth Rate %-54.6ROA % (ttm)7.3Higher Current Ratio y-yN
Dividend Yield %0.5Insider Buy (3m)0ROE % (ttm)19.3Less Shares Outstanding y-yN
Payout Ratio %8.0Shares Outstanding M74.9ROI % (ttm)5.1Gross Margin Increase y-yN

Gurus Latest Trades with BCR

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BCRYacktman Fund 2014-12-31 Reduce-1.42%$144.77 - $172.68
($161.89)
$ 171.036%Reduce -35.51%2,096,000
BCRYacktman Focused Fund 2014-12-31 Reduce-0.82%$144.77 - $172.68
($161.89)
$ 171.036%Reduce -24.93%1,614,000
BCRJoel Greenblatt 2014-09-30 Add0.27%$142.3 - $153.13
($147.81)
$ 171.0316%Add 470.83%229,325
BCRJohn Hussman 2014-09-30 Buy 0.18%$142.3 - $153.13
($147.81)
$ 171.0316%New holding, 15000 sh.15,000
BCRRay Dalio 2014-09-30 Add0.04%$142.3 - $153.13
($147.81)
$ 171.0316%Add 115.75%59,086
BCRYacktman Focused Fund 2014-09-30 Reduce-0.22%$142.3 - $153.13
($147.81)
$ 171.0316%Reduce -6.52%2,150,000
BCRDonald Yacktman 2014-09-30 Reduce-0.15%$142.3 - $153.13
($147.81)
$ 171.0316%Reduce -3.85%6,443,334
BCRRobert Olstein 2014-06-30 Add0.15%$136.23 - $149.25
($142.86)
$ 171.0320%Add 26.67%38,000
BCRJoel Greenblatt 2014-06-30 Add0.05%$136.23 - $149.25
($142.86)
$ 171.0320%Add 187.29%40,174
BCRVanguard Health Care Fund 2014-06-30 Reduce-0.28%$136.23 - $149.25
($142.86)
$ 171.0320%Reduce -37.07%1,157,400
BCRYacktman Fund 2014-06-30 Reduce-0.12%$136.23 - $149.25
($142.86)
$ 171.0320%Reduce -2.76%3,330,000
BCRRay Dalio 2014-06-30 Reduce-0.02%$136.23 - $149.25
($142.86)
$ 171.0320%Reduce -36.59%27,386
BCRVanguard Health Care Fund 2014-03-31 Add0.63%$125.42 - $146.57
($137.91)
$ 171.0324%Add 505.6%1,839,200
BCRRay Dalio 2014-03-31 Add0.03%$125.42 - $146.57
($138.12)
$ 171.0324%Add 118.27%43,186
BCRYacktman Focused Fund 2014-03-31 Reduce-0.91%$125.42 - $146.57
($137.91)
$ 171.0324%Reduce -21.67%2,350,000
BCRDonald Yacktman 2014-03-31 Reduce-0.51%$125.42 - $146.57
($137.91)
$ 171.0324%Reduce -11.96%6,827,627
BCRVanguard Health Care Fund 2013-12-31 Buy 0.13%$113.84 - $139.85
($132.09)
$ 171.0330%New holding, 303700 sh.303,700
BCRYacktman Focused Fund 2013-12-31 Reduce-1.7%$113.84 - $139.85
($132.09)
$ 171.0330%Reduce -29.91%3,000,000
BCRDonald Yacktman 2013-12-31 Reduce-1.09%$113.84 - $139.85
($132.09)
$ 171.0330%Reduce -21.46%7,755,464
BCRYacktman Fund 2013-12-31 Reduce-0.45%$113.84 - $139.85
($132.09)
$ 171.0330%Reduce -9.89%3,500,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BCR is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BCR Yacktman Focused Fund 2014-12-311,614,0002.152.9-24.93%
BCR Yacktman Fund 2014-12-312,096,0002.83-35.51%
BCR John Hussman 2014-09-3015,0000.020.18New Buy
BCR Joel Greenblatt 2014-09-30229,3250.310.33+470.83%
BCR Ray Dalio 2014-09-3059,0860.080.07+115.75%
BCR Donald Yacktman 2014-09-306,443,3348.63.8-3.85%
BCR Vanguard Health Care Fund 2014-09-301,039,1001.390.38-10.22%
BCR Robert Olstein 2014-09-3034,0000.050.63-10.53%
Premium Most recent portfolio changes are included for Premium Members only!


BCR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
RING TIMOTHY MChairman and CEO 2015-01-22Sell20,000$177.84-0.51view
RING TIMOTHY MChairman and CEO 2014-12-22Sell32,325$169.644.3view
Collins Timothy PGroup President 2014-12-17Sell3,960$168.415.07view
Christian Patricia GVP -Quality, Reg & Med Affairs 2014-12-17Sell328$168.025.31view
Luboff Sharon MGroup Vice President 2014-12-17Sell3,564$168.365.1view
Beasley Jim CGroup President 2014-12-17Sell4,525$168.425.06view
Beasley Jim CGroup President 2014-12-16Sell14,634$167.475.65view
DeFord John ASr. VP Sci Tech and Clin Afrs 2014-12-16Sell5,626$167.475.65view
RING TIMOTHY MChairman and CEO 2014-12-16Sell15,232$166.66.21view
WEILAND JOHN HPresident and COO 2014-12-16Sell23,093$166.746.12view

Press Releases about BCR :

Quarterly/Annual Reports about BCR:

News about BCR:

Articles On GuruFocus.com
Becton, Dickinson and Co. (BDX) Dividend Stock Analysis Nov 19 2014 
Weekly 52-Week Highs Highlight: LBTYK, STZ, FISV, BCR Nov 09 2014 
Dividend Aristocrats In Focus Part 19 of 54: CR Bard Oct 15 2014 
Medtronic Inc. (MDT) Dividend Stock Analysis Sep 12 2014 
Paulson, Mindich and Soros Bought Covidien; Should You? Sep 11 2014 
No More a Simple Distributor Sep 07 2014 
Becton, Dickinson and Co. (BDX) Dividend Stock Analysis May 30 2014 
CR Bard Focuses on Small to Medium-Sized Deals Apr 04 2014 
Yacktman Funds Comments on C.R. Bard Inc. Mar 12 2014 
Yacktman Fund Comments on C.R. Bard Inc. Jan 30 2014 


More From Other Websites
C R Bard Inc Earnings Call scheduled for 5:00 pm ET today Jan 29 2015
Bard Announces Fourth Quarter Results Jan 29 2015
4:19 pm C.R. Bard beats by $0.29, beats on revs Jan 29 2015
BARD C R INC /NJ/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jan 29 2015
Bard Announces Fourth Quarter Results Jan 29 2015
Q4 2014 C R Bard Inc Earnings Release - After Market Close Jan 29 2015
Zimmer (ZMH) Likely to Miss Estimates this Earnings Season - Analyst Blog Jan 28 2015
Is Thermo Fisher (TMO) Poised to Surprise Q4 Earnings? - Analyst Blog Jan 28 2015
Will Mead Johnson (MJN) Disappoint Q4 Earnings Estimates? - Analyst Blog Jan 27 2015
Can CR Bard (BCR) Keep the Earnings Streak Alive in Q4? - Analyst Blog Jan 27 2015
CareFusion Banks on Pipeline Strength, Pricing Woes Remain - Analyst Blog Jan 26 2015
Can Illumina (ILMN) Keep the Earnings Streak Alive in Q4? - Analyst Blog Jan 23 2015
Henry Schein to Expand in Animal Health with scil Acquisition - Analyst Blog Jan 20 2015
Teleflex Collaborates with HealthTrust for ARROW Devices - Analyst Blog Jan 15 2015
Henry Schein Expands Dental Practice Transition in Florida - Analyst Blog Jan 15 2015
BARD C R INC /NJ/ Files SEC form 8-K, Other Events Jan 13 2015
And Oil continues to fall... Jan 12 2015
Bard to Host Earnings Conference Call on January 29, 2015 Jan 06 2015
Bard to Host Earnings Conference Call on January 29, 2015 Jan 06 2015
Bard to Present at J.P. Morgan Healthcare Conference Jan 06 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK